Videos

Immunotherapy is a very promising therapy for cancer, but only 15 to 30% of the patients respond to this kind of therapy. Giving immunotherapy to patients without knowing whether they will respond is expensive and can even harm them. That's why Madhavi Andhari is looking for markers to tell apart responders from non-responders.

Imagine having to visit the toilet 30 times a day for 'number two'. That's not possible, right? Unfortunately, it's the reality for a lot of patients with rectal cancer who've had rectal surgery. Anne Asnong tries to help these people so that they no longer have to spend their life 'chained' to the toilet seat. 🚽

Quitting smoking is quite a challenge. In her PhD, Karolien Adriaens (KU Leuven) shows that the e-cigarette is an effective tool to help smokers eventually get rid of their addiction.

Chemotherapy affects the brains of patients. It can lead to cognitive complaints, stress, and fatigue. Michelle Melis achieves promising results with mindfulness in patients with breast cancer. 

What is the link between a smoothie and the analysis of cancer tumours? Well, Sebastiaan Vanuytven explains it smooth(l)y in this video

Melanoma is a very common and lethal type of skin cancer. Melanoma cells have a strange, yet effective defence mechanism called autophagy: they can manage to survive by eating parts of themselves. Monica Vara Perez tries to figure out this self-cannibalism mechanism in order to help defeat melanoma.

Many types of cancer are still being diagnosed too late. The disease has then often already spread, making it difficult to treat the patients. Can we improve early diagnostics in cancer? The answer is hidden in the proteins of the cell, as Guillermo Solis Fernandez explains. 

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why.

Despite recent advances in breast cancer treatment, too many women still die once this cancer has spread throughout their body. That's why Matteo Rossi is looking to find weaknesses of breast cancer cells, in order to defeat them.

Did you know that breast cancer is the second most common cancer for women, affecting 1.7 million women worldwide? In her research Ovia Margaret Thirukkumaran is trying to decipher how cancer cells communicate and develop resistance against drugs in so called HER 2 breast cancer, a very aggressive form of breast cancer.

While an organ transplant will often save the life of a patient, it also leads to a higher risk of developing cancer. Nena Testelmans (KU Leuven) is determined to help unravel why transplants might induce cancer in patients.